CareDx Announces Strategic Minority Investment in Miromatrix
Participation in Series C and Research Partnership to Advance Development of Bioengineered Transplantable OrgansSOUTH SAN FRANCISCO, Calif., May 28, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has closed a minority investment in Miromatrix, a biotechnology company workin...
Source: yahoo.com